Ohio State, Ohio University pool resources to address start-up funding

Brutus Buckeye and Rufus the Bobcat did not attend the announcement

The Ohio State University and Ohio University are partnering to create a new commercialization and funding model. They have committed $35 million in total to the formation of a venture capital fund designed to meet early-stage funding needs of innovative technology ventures.

Ohio State’s commitment to the fund is $20 million and Ohio University has pledged $15 million. The universities also will leverage their resources and assets to bring the best talent, funding and facilities to accelerate entrepreneurial activity and venture creation in Ohio.

“Universities, with our depth of research expertise, creative faculty, business capabilities and eager, well-prepared students, are uniquely positioned to help innovative companies grow and succeed,” said Ohio State President E. Gordon Gee. “We are honored to be partnering with Ohio University to enhance the state’s commercialization ecosystem, building a stronger environment in which to grow our economy.”

“We believe we have identified a new model for technology commercialization success,” said Ohio University President Roderick J. McDavis. “Taking what we have learned on an institutional level and applying it on a larger scale has great potential for our state, our students, faculty, staff, and most importantly, all Ohioans.”

Both institutions are BioOhio Founding Members and boast world-class biomedical research capabilities. It is safe to assume medical and health-related innovations will garner significant attention from the newly created fund.

Get more details in news releases from OSU and OU.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Cardinal Health and Henry Schein long-term agreement to serve physician offices, Cardinal’s physician office-focused organization consolidated into Henry Schein’s Medical Group | Cardinal Health, November 21, 2014

Navidea’s Lymphoseek approved for sale in Europe | Columbus Business First, November 20, 2014

Codonics honored by Frost & Sullivan for enhancing patient safety and accuracy of medication management with the Safe Label System | Frost & Sullivan, November 20, 2014

Microbial Robotics’ new genetics rights management product platform enters international markets with patent filing | PR Newswire, November 19, 2014

Matrix Medical Devices of Cleveland purchases Mentor-based REU Associates | Crains Cleveland Business, November 19, 2014

Global Emerging Pathogen Treatment Consortium formed to study potential of immune plasma treatment in the fight against Ebola, ClinicalRM, USAMRIID | PR Newswire, November 19, 2014

Freedom Meditech granted key U.S. patent covering the ClearPath DS-120 device and method of use | PR Newswire, November 19, 2014

New Ricerca CEO remains positive as questions linger over company | Outsourcing Pharma, November 19, 2014

Cleveland Clinic and Parker Hannifin developing hundreds of potential medical advancments | MedCity News, November 18, 2014

Ohio State University Comprehensive Cancer Center researcher wins supercomputing award for cancer research | Ohio Supercomputer Center, November 18, 2014

CTI Clinical Trial and Consulting Services opens office in Belgium, their sixth new location this year | Cincinnati Business Courier, November 18, 2014

Successful “Date Certain M&A” of AxioMed Spine Corp. its assets and intellectual property | Gerbsman Partners, November 18, 2014

889 Global Solutions profiled by WOSU Career Connections Series (video) | WOSU Public Media via YouTube, November 18, 2014

Duke University Hospital using technology from Dayton-area firm, Riverain Technologies | Dayton Business Journal, November 18, 2014

Ricerca Biosciences acquired by Main Market Partners, a growth-oriented equity investment group | PR Newswire, November 18, 2014

STATKING Clinical Services celebrates 25 years serving the pharmaceutical and medical device industry | BioOhio, November 18, 2014

EnzymeBioSystems announces an independent research group reported breast cancer preventive efficacy for a novel synthetic triterpenoid | PR Newswire, November 17, 2014

Summa Health System names Dr. Thomas Malone as new CEO | Cleveland.com, November 17, 2014

Invacare announces retirement of Joseph Richey, President Technologies Division, Sr VP Electronic and Design Engineering | Business Wire, November 17, 2014

Ohio doctor’s method could reduce breast cancer treatment risks, University of Toledo, ProMedica Health | Toledo Free Press, November 15, 2014